Clinical Epidemiology and Ageing

Optimisation of treatments for heart failure with reduced ejection fraction in routine practice: a position statement from a panel of experts.

Girerd N, Leclercq C, Hanon O, Bayes-Génis A, Januzzi JL, Damy T, Lequeux B, Meune C, Sabouret P, Roubille F Rev Esp Cardiol (Engl Ed). 2023.

Major international practice guidelines recommend the use of a combination of 4 medication classes in the treatment of patients with heart failure with reduced ejection fraction (HFrEF) but do not specify how these treatments should be introduced and up-titrated. Consequently, many patients with HFrEF do not receive an optimized treatment regimen. This review proposes a pragmatic algorithm for treatment optimization designed to be easily applied in routine practice. The first goal is to ensure that all 4 recommended medication classes are initiated as early as possible to establish effective therapy, even at a low dose. This is considered preferable to starting fewer medications at a maximum dose. The second goal is to ensure that the intervals between the introduction of different medications and between different titration steps are as short as possible to ensure patient safety. Specific proposals are made for older patients (> 75 years) who are frail, and for those with cardiac rhythm disorders. Application of this algorithm should allow an optimal treatment protocol to be achieved within 2-months in most patients, which should the treatment goal in HFrEF.

DOI: 10.1016/j.rec.2023.03.005